VivoSim Labs, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
VivoSim Labs, Inc. (VIVS) had Lessee, Operating Lease, Liability, to be Paid, Year One of $459.00 thousand as of 2026-03-31, per its 10-K filed 2026-07-14.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-07-14
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $459.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $138.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $271.00K.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $404.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-03-31 | $459.00K 10-K · filed 2026-07-14 |
| 2025-12-31 | $138.00K 10-Q · filed 2026-02-11 |
| 2025-09-30 | $271.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $404.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $538.00K 10-K · filed 2025-06-05 |
| 2024-12-31 | $538.00K 10-Q · filed 2025-02-19 |
| 2024-09-30 | $538.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $538.00K 10-Q · filed 2024-08-05 |
| 2023-12-31 | $523.00K 10-Q · filed 2024-02-08 |
| 2023-09-30 | $523.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $523.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $508.00K 10-K · filed 2023-07-14 |
| 2022-12-31 | $508.00K 10-Q · filed 2023-02-09 |
| 2022-09-30 | $509.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $509.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $495.00K 10-K · filed 2022-06-10 |
| 2021-12-31 | $495.00K 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |